Skip to Main Content

Author Details

Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
1986
36
17
PMIDPaper TitleJournal TitlePublished Year
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
35965547High Dose "HDR-Like" Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial.Front Oncol2022
34836735Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.Clin Oncol (R Coll Radiol)2022
32900561Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2021
33493615Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.Int J Radiat Oncol Biol Phys2021
34585025Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.Adv Radiat Oncol2021
33965893Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.Cancer Treat Rev2021
33358229Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.Int J Radiat Oncol Biol Phys2021
33035622Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.Radiother Oncol2021
31629838Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.Int J Radiat Oncol Biol Phys2020
33384965Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer.Front Oncol2020
32670876Prostate SBRT: Comparison the Efficacy and Toxicity of Two Different Dose Fractionation Schedules.Front Oncol2020
31108142Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.Int J Radiat Oncol Biol Phys2019
30735235Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.JAMA Netw Open2019
27322703A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.Am J Clin Oncol2018
30056080Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial.Int J Radiat Oncol Biol Phys2018
31158102Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes.Eur Urol Oncol2018
26059509High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.Pract Radiat Oncol2015
25185083Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer.J Clin Oncol2014
25505732Virtual HDR CyberKnife SBRT for Localized Prostatic Carcinoma: 5-Year Disease-Free Survival and Toxicity Observations.Front Oncol2014
24060175Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.Radiother Oncol2013
24119836Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials.Int J Radiat Oncol Biol Phys2013
21940578Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy.AJR Am J Roentgenol2011
19147029Balancing on a knife's edge: evidence-based medicine and the marketing of health technology. In regard to Bentzen et al. (Int J Radiat Oncol Biol Phys 2008;72:12-14).Int J Radiat Oncol Biol Phys2009
18374232Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.Int J Radiat Oncol Biol Phys2008
17964222Computed tomography-ultrasound fusion brachytherapy: description and evolution of the technique.Brachytherapy2007
17994791Robotic radiosurgery vs. brachytherapy as a boost to intensity modulated radiotherapy for tonsillar fossa and soft palate tumors: the clinical and economic impact of an emerging technology.Technol Cancer Res Treat2007
16182221CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases.Brachytherapy2005
15110308Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors.Brachytherapy2004
10235143Prostatectomy, external beam radiation therapy, or brachytherapy for localized prostate cancer.JAMA1999
8179375Superior sulcus tumors: combined modality.Ann Thorac Surg1994
1454140Late effects following central nervous system radiation in a pediatric population.Neuropediatrics1992
2347711Analysis of preoperative intracavitary cesium application versus postoperative external beam radiation in stage I endometrial carcinoma.Int J Radiat Oncol Biol Phys1990
2457005Radiotherapy for chordoma.Int J Radiat Oncol Biol Phys1988
3585445Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.J Clin Oncol1987
3013398Malignant testicular germ cell tumors in a father and two sons. Case report and literature review.Cancer1986
  • 1 - 36 of 36

Recommended Authors

Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 19
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 2
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 11
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 6
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 11
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 10
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Career Start Year 2004
Number of shared co-authors 20
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 34
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 0
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 21
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 19
Danny Y Song
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 18
Brian J Moran
Chicago Prostate Cancer Center
Career Start Year 1999
Number of shared co-authors 16
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 13
Brian J Davis
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 21
Eric Vigneault
Centre Hospitalier Universitaire de Quebec
Career Start Year 1997
Number of shared co-authors 8
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 10
Eric M Horwitz
Fox Chase Cancer Center
Career Start Year 1996
Number of shared co-authors 33
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 6
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 19
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 17
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 13
Thomas M Pisansky
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 21
Richard G Stock
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 32
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 19
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 14
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 19
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 18
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 22

Collaborators

Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 12
Michael L Steinberg
University of California los angeles
Co-authored papers 9
Alan W Katz
University of Rochester
Co-authored papers 8
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 7
Amar U Kishan
University of California los angeles
Co-authored papers 6
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 6
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 6
Constantine A Mantz
University of Chicago
Co-authored papers 5
Christopher R King
University of California los angeles
Co-authored papers 5
Mark K Buyyounouski
Stanford University
Co-authored papers 4
Hilary P Bagshaw
Stanford University
Co-authored papers 4
Simeng Suy
MedStar Georgetown University Hospital
Co-authored papers 4
Ye Yuan
Southwest Hospital, Army Medical University
Co-authored papers 4
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 4
Naomi Y Jiang
University of California los angeles
Co-authored papers 3
Shrinivasa K Upadhyaya
University of California davis
Co-authored papers 2
Jesus E Juarez
University of California Los Angeles
Co-authored papers 2
Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Rebecca Levin-Epstein
University of California los angeles
Co-authored papers 2
Amar U Kishan
University of California los angeles
Co-authored papers 2
Leszek Miszczyk
MSC National Research Institute of Oncology Gliwice Branch
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Audrey Dang
Tulane University School of Medicine
Co-authored papers 2
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 2
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Agnieska Namys??-Kaletka
Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Co-authored papers 1
Rebecca Philipson
Torrance Memorial Hospital
Co-authored papers 1
Release 1.2